A strategy for prophylactic vaccination against HIV.
Salk
J
J
Salk Institute for Biological Studies, San Diego, CA 92138.
Bretscher
P A
PA
Salk
P L
PL
Clerici
M
M
Shearer
G M
GM
D016915:AIDS Vaccines; D000163:Acquired Immunodeficiency Syndrome / Q000276:immunology / Q000517:prevention & control*; D000276:Adjuvants, Immunologic; D000818:Animals; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology; D016207:Cytokines / Q000276:immunology; D015483:HIV Antibodies / Q000096:biosynthesis; D015488:HIV Antigens / Q000276:immunology; D015658:HIV Infections / Q000276:immunology / Q000517:prevention & control*; D000882:Haplorhini; D006801:Humans; D007111:Immunity, Cellular; D007156:Immunologic Memory; D051379:Mice; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology; D014611:Vaccination
D016915:AIDS Vaccines; D000276:Adjuvants, Immunologic; D016207:Cytokines; D015483:HIV Antibodies; D015488:HIV Antigens